UK first country to approve bivalent vaccine

bivalent

First bivalent COVID-19 booster vaccine approved by UK medicines regulator: The adapted COVID-19 vaccine made by Moderna targets two different coronavirus variants – the original virus from 2020 and the Omicron variant. An updated version of the COVID-19 vaccine made by Moderna that targets two coronavirus variants (known as a “bivalent” vaccine) has today been […]

Read More… from UK first country to approve bivalent vaccine

Guidance on Brexit transition period

transition period

ABPI response to MHRA guidance for the end of the transition period The MHRA has published information for pharmaceutical companies preparing for the end of the Brexit transition period.​ The guidance provides some information on how to operate from 1 January 2021, including on licensing of medicines and devices, clinical trials, exporting active substances for […]

Read More… from Guidance on Brexit transition period